HealthTech Startup Ro Raises $200M Series C Funding

New York-based telehealth startup Ro has secured $200 million in Series C funding at a $1.5 billion valuation. The round was led by General Catalyst with participation from existing investors. Ro operates a direct-to-patient healthcare platform offering telemedicine, pharmacy services, and at-home diagnostics. The company plans to expand its service offerings and geographic reach.